Pancreatic follicular lymphoma: a report of two cases and literature review.


Journal

Clinical journal of gastroenterology
ISSN: 1865-7265
Titre abrégé: Clin J Gastroenterol
Pays: Japan
ID NLM: 101477246

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 19 07 2021
accepted: 23 08 2021
pubmed: 29 8 2021
medline: 3 11 2021
entrez: 28 8 2021
Statut: ppublish

Résumé

Primary pancreatic lymphomas are extremely rare, accounting for 0.1-0.5% of malignant lymphomas and about 0.2% of primary pancreatic tumors. They occur most commonly in the pancreatic head of elderly males, with diffuse large B-cell lymphoma being the most common subtype. Primary pancreatic follicular lymphoma is the most commonly reported primary pancreatic indolent lymphoma, accounting for 9-14% of primary pancreatic lymphomas. We report two cases of primary pancreatic follicular lymphoma treated with obinutuzumab, a second-generation humanized anti-CD20 monoclonal antibody, and bendamustine. One was diagnosed by endoscopic ultrasound-guided fine-needle aspiration, while the other required laparoscopic lymph node sampling to reach a diagnosis. Both achieved complete response with induction therapy and opted for maintenance therapy with obinutuzumab. We also conducted a literature review of primary pancreatic follicular lymphoma cases reported over the last 30 years.

Identifiants

pubmed: 34453279
doi: 10.1007/s12328-021-01507-2
pii: 10.1007/s12328-021-01507-2
pmc: PMC8395385
doi:

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1756-1765

Informations de copyright

© 2021. Japanese Society of Gastroenterology.

Références

Ezzat A, Jamshed A, Khafaga Y, et al. Primary pancreatic non-Hodgkin’s lymphomas. J Clin Gastroenterol. 1996;23:109–12.
doi: 10.1097/00004836-199609000-00008
Malin ES, Tomey CE, Ono J, et al. Primary pancreatic lymphoma. Blood. 2010;116:4150.
doi: 10.1182/blood.V116.21.4150.4150
Baylor SM, Berg JW. Cross-classification and survival characteristics of 5000 cases of cancer of the pancreas. J Surg Oncol. 1973;5:335–58.
doi: 10.1002/jso.2930050410
Facchinelli D, Sina S, Boninsegna E, et al. Primary pancreatic lymphoma: clinical presentation, diagnosis, treatment, and outcome. Eur J Haematol. 2020;105:468–75.
doi: 10.1111/ejh.13468
WHO Classification of Tumours Editorial Board. Digestive system tumors. Lyon (France): International Agency for Research on Cancer; 2019. (WHO classification of tumors series, 5th ed.; vol. 1): 376–407.
Prayer L, Schurawitzki H, Mallek R, et al. CT in pancreatic involvement of non-Hodgkin lymphoma. Acta Radiol. 1992;33:123–7.
doi: 10.1177/028418519203300208
Behrns KE, Sarr MG, Strickler JG. Pancreatic lymphoma: is it a surgical disease? Pancreas. 1994;9:662–7.
doi: 10.1097/00006676-199409000-00019
Bouvet M, Staerkel GA, Spitz FR, et al. Primary pancreatic lymphoma. Surgery. 1998;123:382–90.
doi: 10.1016/S0039-6060(98)70158-8
Koniaris LG, Lillemoe KD, Yeo CJ, et al. Is there a role for surgical resection in the treatment of early-stage pancreatic lymphoma? J Am Coll Surg. 2000;190:319–30.
doi: 10.1016/S1072-7515(99)00291-4
Nishimura R, Takakuwa T, Hoshida Y, et al. Primary pancreatic lymphoma: clinicopathological analysis of 19 cases from Japan and review of the literature. Oncology. 2001;60:322–9.
doi: 10.1159/000058528
Volmar KE, Routbort MJ, Jones CK, et al. Primary pancreatic lymphoma evaluated by fine-needle aspiration: findings in 14 cases. Am J Clin Pathol. 2004;121:898–903.
doi: 10.1309/UAD9PYFUA82X9R9U
Grimison PS, Chin MT, Harrison ML, et al. Primary pancreatic lymphoma–pancreatic tumours that are potentially curable without resection, a retrospective review of four cases. BMC Cancer. 2006;6:117.
doi: 10.1186/1471-2407-6-117
Sata N, Kurogochi A, Endo K, et al. Follicular lymphoma of the pancreas: a case report and proposed new strategies for diagnosis and surgery of benign or low-grade malignant lesions of the head of the pancreas. JOP. 2007;8:44–9.
pubmed: 17228133
Ravi K, Sanchez W, Sweetser S. Primary pancreatic follicular lymphoma mimicking adenocarcinoma. Clin Gastroenterol Hepatol. 2010;8:e101–2.
doi: 10.1016/j.cgh.2010.05.011
Alexander RE, Nakeeb A, Sandrasegaran K, et al. Primary pancreatic follicle center-derived lymphoma masquerading as carcinoma. Gastroenterol Hepatol (N Y). 2011;7:834–8.
Shirai Y, Okamoto T, Kanehira M, et al. Pancreatic follicular lymphoma presenting as acute pancreatitis: report of a case. Int Surg. 2015;100:1078–83.
doi: 10.9738/INTSURG-D-14-00132.1
Boninsegna E, Zamboni GA, Facchinelli D, et al. CT imaging of primary pancreatic lymphoma: experience from three referral centres for pancreatic diseases. Insights Imaging. 2018;9:17–24.
doi: 10.1007/s13244-017-0585-y
Sallapan S, Abu Bakar NZ, Jarmin R, et al. Primary follicular lymphoma of the pancreas: a rare tumour mimicking pancreatic carcinoma. Malays J Pathol. 2018;40:359–71.
pubmed: 30580370
Sadot E, Yahalom J, Do RK, et al. Clinical features and outcome of primary pancreatic lymphoma. Ann Surg Oncol. 2015;22:1176–84.
doi: 10.1245/s10434-014-4176-6
Marcus R, Davies A, Ando K, et al. Obinutuzumab for the first-line treatment of follicular lymphoma. N Engl J Med. 2017;377:1331–44.
doi: 10.1056/NEJMoa1614598
Tepasse PR, Hafezi W, Lutz M, et al. Persisting SARS-CoV-2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature. Br J Haematol. 2020;190:185–8.
doi: 10.1111/bjh.16896
Anand D, Lall C, Bhosale P, et al. Current update on primary pancreatic lymphoma. Abdom Radiol (NY). 2016;41:347–55.
doi: 10.1007/s00261-015-0620-8
Yasuda I, Tsurumi H, Omar S, et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy for lymphadenopathy of unknown origin. Endoscopy. 2006;38:919–24.
doi: 10.1055/s-2006-944665
Mie T, Sasaki T, Kanata R, et al. Comparison of endoscopic ultrasound-guided tissue acquisition using a 20-gauge Menghini needle with a lateral forward bevel and a 22-gauge Franseen needle a single-center large cohort study. Clin Endosc. 2021. https://doi.org/10.5946/ce.2020.251 .
doi: 10.5946/ce.2020.251 pubmed: 33657780 pmcid: 8505170
Mie T, Sasaki T, Kanata R, et al. Diagnostic yield of endoscopic ultrasound-guided tissue acquisition for small solid pancreatic lesions. Endosc Int Open. 2020;8:E1359–64.
doi: 10.1055/a-1230-3555
Savari O, Al-Duwal Z, Wang Z, et al. Pancreatic lymphoma: a cytologic diagnosis challenge. Diagn Cytopathol. 2020;48:350–5.
doi: 10.1002/dc.24349
Kopel J, Swarup K, Thein K, et al. Primary B cell lymphoma of the pancreas. J Gastrointest Cancer. 2020;51(3):1077–80.
doi: 10.1007/s12029-020-00400-4
National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). B-cell Lymphomas Version 4.2021—May 5, 2021. Available from: https://www.nccn.org/ . Accessed 29 May 2021.
Ardeshna KM, Smith P, Norton A, et al. Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. Lancet. 2003;362:516–22.
doi: 10.1016/S0140-6736(03)14110-4
Yuda S, Maruyama D, Maeshima AM, et al. Influence of the watch and wait strategy on clinical outcomes of patients with follicular lymphoma in the rituximab era. Ann Hematol. 2016;95:2017–22.
doi: 10.1007/s00277-016-2800-1
Manna M, Lee-Ying R, Davies G, et al. Autologous transplantation improves survival rates for follicular lymphoma patients who relapse within two years of chemoimmunotherapy: a multi-center retrospective analysis of consecutively treated patients in the real world. Leuk Lymphoma. 2019;60:133–41.
doi: 10.1080/10428194.2018.1473576

Auteurs

Takeshi Okamoto (T)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Takashi Sasaki (T)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan. sasakit-tky@umin.ac.jp.

Noriko Nishimura (N)

Department of Hematology Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Manabu Takamatsu (M)

Department of Pathology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Chinatsu Mori (C)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Takafumi Mie (T)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Takaaki Furukawa (T)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Yuto Yamada (Y)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Tsuyoshi Takeda (T)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Akiyoshi Kasuga (A)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Masato Matsuyama (M)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Masato Ozaka (M)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Dai Maruyama (D)

Department of Hematology Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Naoki Sasahira (N)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH